Evogene | EVGN - Ebitda

Stock Price
244.80
Daily Change
2.10 0.87%
Monthly
-13.28%
Yearly
-38.74%
Q2 Forecast
237.60

Evogene reported $-4.95M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
CVR Partners USD 70.62M 3.41M Sep/2025
Evogene USD -4.95M 2.51M Dec/2025
Globe Specialty Metals USD 14.59M 3.68M Dec/2025
Hawkins USD 35.97M 11.96M Dec/2025
Innospec USD 55.7M 12.4M Dec/2025
Intrepid Potash USD 6.85M 119K Sep/2024
Koppers USD 53.2M 17.7M Dec/2025
Kronos Worldwide USD -57.9M 58.5M Dec/2025
LSB Industries USD 54.08M 13.98M Dec/2025
Materion USD 57M 1.5M Dec/2025
Minerals Technologies USD 87.3M 13M Dec/2025
Rayonier Advanced Materials USD 46M 2.5M Dec/2025
Sensient Technologies USD 86.04M 23.01M Mar/2026
Stepan USD 33.8M 22.4M Dec/2025
Tronox USD 57M 17M Dec/2025
Valhi USD 24.4M 21.4M Sep/2025
WD-40 USD 28.66M 3.3M Dec/2025